<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02744599</url>
  </required_header>
  <id_info>
    <org_study_id>IRB_00056695</org_study_id>
    <secondary_id>R43NR015955</secondary_id>
    <nct_id>NCT02744599</nct_id>
  </id_info>
  <brief_title>Feasibility Trial for Detecting Drug-induced Respiratory Depression and Prompting for Self-rescue</brief_title>
  <official_title>Feasibility Trial for Detecting Drug-induced Respiratory Depression and Prompting for Self-rescue</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Utah</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Institute of Nursing Research (NINR)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Utah</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a small trial to test feasibility of an idea for a potential device. The
      investigators tested the feasibility of prompting a volunteer to breathe when their breathing
      had slowed down during administration of anesthetic drugs.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>October 2013</start_date>
  <completion_date type="Actual">March 2015</completion_date>
  <primary_completion_date type="Actual">March 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Other</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Breath prompting successful rate</measure>
    <time_frame>Change in respiratory rate from baseline to the period 10 seconds after the breath prompt</time_frame>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">26</enrollment>
  <condition>Healthy</condition>
  <arm_group>
    <arm_group_label>Device prompting</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Patients receive standard of care</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Prompting breaths via recorded voice, vibrating massager, and/or muscle tetany</intervention_name>
    <description>Prompt volunteer to breathe using device to play recorded voice, massage the body, and/or apply muscle tetany</description>
    <arm_group_label>Device prompting</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  American Society of Anesthesia (ASA) Class I and Class II male and female
             (non-pregnant/non-lactating) volunteers.

          -  Normal healthy individual as indicated by medical history and a physical examination.

          -  At least 18 years of age and less than 55 years of age.

          -  Negative drug screen.

          -  Uncomplicated airway anatomy.

          -  A Body Mass Index between 18 and 32.

          -  Are fully informed of the risks of entering the study and willingly provide written
             consent to enter the trial.

          -  Female subjects of child bearing potential will have a negative urine pregnancy test
             on the day the study is conducted.

        Exclusion Criteria:

          -  Known or suspected neurological pathologies.

          -  A history of significant alcohol or drug abuse, a history of allergy to opioids or
             propofol, or a history of chronic drug requirement or medical illness that is known to
             alter the pharmacokinetics or pharmacodynamics of remifentanil and propofol.

          -  Known obstructive sleep apnea.

          -  Known or suspected hypersensitivity to any compound present in the study.

          -  Any potential subject suffering from medical problems that, in the judgment of the
             investigator, presents unacceptable risk to the volunteer are not eligible for
             enrollment.

          -  Vulnerable subject groups such as prisoners and the mentally disabled that are
             traditionally excluded from medical research are also excluded.

          -  The potential subject has taken any medication within 2 days prior to chosen drug
             administration, with the exception of oral contraceptives.

          -  The potential subject is wearing artificial nails.

          -  A positive urine pregnancy test (females only)

          -  Female subjects who are currently lactating &amp; breast-feeding.

          -  A positive drug-screening test.

          -  The subject consumed food or fluids within 8 hours prior to start of each chosen drug
             administration.

          -  Any medications or alcohol within 2 days prior to start of the chosen drug
             administration, with the exception of oral contraceptives.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>55 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <verification_date>May 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 7, 2016</study_first_submitted>
  <study_first_submitted_qc>April 19, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 20, 2016</study_first_posted>
  <last_update_submitted>May 1, 2018</last_update_submitted>
  <last_update_submitted_qc>May 1, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">May 7, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Utah</investigator_affiliation>
    <investigator_full_name>Lara Brewer</investigator_full_name>
    <investigator_title>Research Assistant Professor</investigator_title>
  </responsible_party>
  <keyword>Feasibility trial</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Depression</mesh_term>
    <mesh_term>Respiratory Insufficiency</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

